DKSC.US Dakshidin Corporatio

Healthcare Pharmaceuticals USA Stocks
0.0003 USD
Close of Nov 12, 2026
0.0001 0.0007
Market cap
USD 1.33M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is DKSC.US undervalued?

Graham number

The Graham number of Dakshidin Corporatio cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Dakshidin Corporatio fundamental analysis

No fundamental analysis for Dakshidin Corporatio yet.

Dakshidin Corporatio stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Dakshidin Corporatio

Dakshidin Corporation, Inc., does not have significant operations. The company intends to pursue a business acquisition and is evaluating potential business opportunities. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its name to Dakshidin Corporation, Inc. in February 2007. The company was incorporated in 2007 and is based in Lockport, Illinois.

Full company profile